Local News: Eight Mile, AL 

 | 

Sign Up

 | 

Sign In

Advertisment

Amaryl, Glimepiride

Amaryl, Glimepiride Wire

Comprehensive News Feed for Amaryl, Glimepiride (generic).

Results 1 - 20 of 29 in Amaryl, Glimepiride (generic)

  1. New Study Results Show That Patients Have Higher Treatment...Read the original story

    Saturday Oct 24 | Drugs.com

    MONTREAL, Oct. 22 /CNW/ - New data on patient treatment satisfaction from the LEAD 6 trial presented on the 22nd October at the 20th World Diabetes Congress shows that patients have higher overall treatment satisfaction with liraglutide than they do with exenatide.

    Comment?

  2. Diabetes drugs may leave heart at greater riskRead the original story

    Friday Oct 23 | Los Angeles Times

    Medications for Type 2 diabetes are very effective at controlling blood sugar levels.

    Comment?

    Related Topix: Medicine, Diabetes, Health, Metformin (generic), Glucophage

  3. New Study Results Show That Patients Have Higher Treatment...Read the original story

    Thursday Oct 22 | Canada NewsWire

    To view the Multimedia News Release, please click: Specifically, among the 379 patients who completed the Diabetes Treatment Satisfaction Questionnaires during the LEAD 6 trial, those taking liraglutide perceived less hypoglycaemia or hyperglycaemia compared to those on exenatide.

    Comment?

  4. Sulfonylureas May Elevate Risk in MI Survivors (MI as in myocardial...

    Oct 14, 2009 | Free Republic

    Four widely prescribed oral sulfonylurea drugs are associated with significantly increased risk of all-cause mortality compared with metformin in type 2 diabetic patients having a history of MI, according to a comprehensive Danish national cohort study.

    Comment?

    Related Topix: Medicine, Metformin (generic), Glucophage, Medication, Glucotrol, Glipizide (generic), Glyburide (generic), Micronase, Diabeta, Orinase, Tolbutamide (generic), Prandin, Repaglinide (generic)

  5. Alpha-Glucosidase InhibitorsRead the original story

    Oct 3, 2009 | Diabetes Self Management

    A class of diabetes drugs sometimes called “starch blockers” that blocks the action of enzymes that normally begin to break down certain carbohydrates in the upper part of the small intestine.

    Comment?

    Related Topix: Medicine, Diabetes, Health, Metformin (generic), Glucophage, Medication, Glyburide (generic), Micronase, Diabeta, Glucotrol, Glipizide (generic), Starlix, Nateglinide (generic)

  6. New Data Shows That Type 2 Diabetes Patients Who Start Insulin...Read the original story

    Oct 2, 2009 | BusinessWire

    Data from a new study presented today at the annual meeting of the European Association for the Study of Diabetes shows that type 2 diabetes patients starting insulin treatment with once-daily injection of NovoMix 30 achieve a significantly greater HbA1c reduction compared to patients starting with a daily injection of insulin glargine.

    Comment?

    Related Topix: Medicine, Insulin (generic), Humulin, Novolin, Diabetes, Health, Lantus, Insulin Glargine (generic)

  7. Insulin ResistanceRead the original story

    Aug 9, 2009 | Diabetes Self Management

    A condition in which the body needs extra insulin to maintain normal blood sugar levels.

    Comment?

    Related Topix: Medicine, Insulin (generic), Humulin, Novolin, Medication, Diabetes, Health, Glyburide (generic), Micronase, Diabeta, Glucotrol, Glipizide (generic), Prandin, Repaglinide (generic)

  8. 2009 August 05 Read the original story w/Photo

    Aug 5, 2009 | All Bronx News, All the Time!

    Archive for August 5th, 2009 El Paso taquerias, a sizzling success El Paso taquerias, a sizzling success The terrace at the new El Paso Taqueria.

    Comment?

  9. Novo Nordisk study finds once-daily liraglutide reduces blood sugar, weight in African-AmericansRead the original story

    Aug 5, 2009 | All Bronx News, All the Time!

    LAS VEGAS A study by Novo Nordisk concluded that once-daily liraglutide, an investigational treatment for Type 2 diabetes, leads to statistically significant and sustained reductions in blood sugar and weight in African-Americans with Type 2 diabetes, as compared with glimepiride, a commonly prescribed diabetes treatment.

    Comment?

    Related Topix: African-American, Medicine, Health, Diabetes

  10. Novo Nordisk study finds once-daily liraglutide reduces blood sugar, weight in African-AmericansRead the original story

    Jul 29, 2009 | Drug Store News

    LAS VEGAS A study by Novo Nordisk concluded that once-daily liraglutide, an investigational treatment for Type 2 diabetes, leads to statistically significant and sustained reductions in blood sugar and weight in African-Americans with Type 2 diabetes, as compared with glimepiride, a commonly prescribed diabetes treatment.

    Comment?

    Related Topix: African-American, Medicine, Health, Diabetes, Medication

  11. Liraglutide Lowered Blood Sugar and Weight in African Americans With...Read the original story

    Jul 27, 2009 | PR-inside.com

    The data were presented at the 114th National Medical Association Annual Convention & Scientific Assembly.

    Comment?

    Related Topix: African-American, Medicine, Diabetes, Health, Biotech, Novo Nordisk AS, Medication

  12. Liraglutide Lowered Blood Sugar and Weight in African Americans With...

    Jul 25, 2009 | Earth Times

    The data were presented at the 114th National Medical Association Annual Convention & Scientific Assembly.

    Comment?

    Related Topix: African-American, Medicine, Diabetes, Health, Biotech, Novo Nordisk AS, Medication

  13. Diabetic Claims Jail Did Not Give Needed MedicationRead the original story

    Jul 21, 2009 | Cape May County Herald

    Gary Arrington, 45, of Whitesboro spent two days in Cape May County Jail on a contempt charge for child support, and claimed during that time, he was not allowed to take medications for his diabetes and back pain.

    Comment?

    Related Topix: Cape May County, NJ

  14. Two-Year Data Show Investigational Drug Liraglutide More Effective at ...Read the original story

    Jun 10, 2009 | Drugs.com

    Novo Nordisk data presented at the 69th Annual Scientific Sessions of the American Diabetes Association showed that once-daily liraglutide, taken as monotherapy, leads to statistically significant and sustained reductions in blood sugar and weight after two years of treatment.

    Comment?

    Related Topix: Medicine, Diabetes, Health, Biotech, Novo Nordisk AS, Medication, Fasting

  15. New Data From Boehringer Ingelheim's Ongoing Linagliptin Trial...Read the original story

    Jun 9, 2009 | Medical News Today

    Study results presented for the first time in the scientific sessions of this year's American Diabetes Association Annual Meeting show clinically relevant and statistically significant reductions in haemoglobin A1c and fasting plasma glucose levels when linagliptin, a dipeptidyl peptidase 4 inhibitor, is given as add-on therapy in Type 2 diabetic ...

    Comment?

    Related Topix: Medicine, Diabetes, Health, Fasting, Metformin (generic), Glucophage

  16. New Diabetes Drug Shows Promise in TrialRead the original story

    Jun 8, 2009 | MedicineNet

    An experimental diabetes drug called liraglutide appears to outperform exenatide , the only currently approved drug in its class, a study funded by liraglutide's maker, Novo Nordisk, shows.

    Comment?

    Related Topix: Medicine, Diabetes, Health, Insulin (generic), Humulin, Novolin, Medication, Food and Drug Administration, Fasting, Baylor College of Medicine

  17. New Diabetes Drug Shows Promise in TrialRead the original story

    Jun 9, 2009 | CBC News

    An experimental diabetes drug called liraglutide appears to outperform exenatide , the only currently approved drug in its class, a study funded by liraglutide's maker, Novo Nordisk, shows.

    Comment?

    Related Topix: Medicine, Diabetes, Health, Insulin (generic), Humulin, Novolin, Medication, Food and Drug Administration, Fasting, Science / Technology

  18. New Data From Boehringer Ingelheim's Ongoing Linagliptin Trial...Read the original story

    Jun 9, 2009 | MediLexicon

    Study results presented for the first time in the scientific sessions of this year's American Diabetes Association Annual Meeting show clinically relevant and statistically significant reductions in haemoglobin A1c and fasting plasma glucose levels when linagliptin, a dipeptidyl peptidase 4 inhibitor, is given as add-on therapy in Type 2 diabetic ...

    Comment?

    Related Topix: Medicine, Diabetes, Health, Fasting, Metformin (generic), Glucophage

  19. Boehringer Ingelheim Unveils Diabetes PipelineRead the original story

    Jun 9, 2009 | Pharmaceutical Online

    Boehringer Ingelheim Pharmaceuticals, Inc. today announced its pipeline of oral antidiabetic compounds, establishing itself in the type 2 diabetes therapeutic area.

    Comment?

    Related Topix: Medicine, Diabetes, Health, Metformin (generic), Glucophage, Healthcare Law, Law, Food and Drug Administration

  20. Study finds Novo Nordisk diabetes drug works better than originalRead the original story

    Jun 8, 2009 | Drug Store News

    NEW ORLEANS Results of a phase 3 study presented Sunday at the American Diabetes Associationa s 69th annual scientific sessions indicates that an investigational diabetes drug works better than a drug originally made by Sanofi-Aventis. Danish drug maker Novo Nordisk presented data showing that liraglutide was more effective at lowering blood sugar ...

    Comment?

    Related Topix: Medicine, Diabetes, Health, Medication